Ucn2 (urocortin 2) has been shown to exert potent beneficial effects in the cardiovascular system, including inhibition of apoptosis, improvement of cardiomyocyte contractility and decrease of oxidative stress. The mechanisms that contribute to the regulation of hUcn2 (human Ucn2) expression in cardiovascular pathologies are not known. In the present study, we analysed the mechanism by which hypoxia, a major stimulus in ischaemic heart disease, regulates Ucn2 gene expression. Hypoxia and CPX (ciclopirox olamine), which prevents proteolytic degradation of HIF (hypoxia-inducible factor), significantly increased hUcn2 mRNA levels in TE-671 cells. Gene silencing of endogenous HIF1α abolishes this increase. Hypoxia and CPX activated a luciferase-linked fragment of the 3 FLR (3 -flanking region) of the hUcn2 gene containing two putative HREs (hypoxiaresponse elements), HRE1 and HRE2. Site-directed mutagenesis experiments demonstrated that HRE1 is required for HIF1α-dependent luciferase activation. This activation was conserved in constructs with the 3 FLR fragment placed upstream of the luciferase gene, indicating an enhancer function for HRE1. Competition assays revealed direct binding between HRE1 and HIF1α. Regulation of Ucn2 by hypoxia was confirmed in rat neonatal cardiomyocytes and in cardiac-derived H9c2 cells transfected with constructs of the 3 FLR of the hUcn2 gene. In conclusion, our study demonstrates that hypoxia induces hUcn2 expression via a specific HRE in the 3 FLR of the hUcn2 gene, which interacts with the transcription factor HIF1α. Hypoxiamediated stimulation of cardioprotective Ucn2 may help to preserve cardiac function and prevent apoptosis in ischaemic conditions in the heart.
INTRODUCTION
Tissue hypoxia is a feature of various pathologies, including cancer, cardiovascular disease and cerebrovascular disease. Hypoxia is an important component of ischaemia, in which reduced blood flow leads to diminished tissue oxygen supply. Severe acute hypoxia in the heart, e.g. after interrupted coronary blood flow, results in cardiac damage, ultimately becoming manifest as myocardial infarction. During the process of cardiac remodelling that occurs in ischaemic heart disease, hypoxia contributes to protective adaptations such as the activation of survival pathways, metabolic remodelling, the induction of angiogenesis and changes in cardiac gene expression towards a fetal pattern. A variety of cardiac peptide hormones are induced during ischaemia-reperfusion and remodelling, in part as a cardioprotective programme. Development towards left ventricular dysfunction correlates with the relative expression levels of these factors [1] .
Previously, distinct peptides of the CRF (corticotropinreleasing factor)-related peptides, named Ucns (urocortins) 1,2, and 3 [2, 3] , were shown to have potent beneficial effects in the heart, such as inhibition of apoptosis, improvement of cardiomyocyte contractile function, reduction of oxidative stress, and vasodilation [4] [5] [6] . These cardioprotective effects are predominantly mediated by the CRFR2 (CRF receptor 2), which is the only CRFR subtype found in the heart and preferentially bound by Ucn2 and Ucn3 [7] . Ucn2 is expressed in peripheral tissues such as kidney, lung, skeletal muscle as well as blood cells, and notably, it is also produced by cardiac myocytes [8] [9] [10] . Ucn2 may therefore be one of the peptides of the cardioprotective programme induced by hypoxia.
In line with this, recent reports indicate that Ucn2 infusion increases cardiac output and left ventricular ejection fraction in patients with mild stable heart failure [11] . Ucn2 was shown to improve myocardial contractility in a murine heart failure model [12] . In experimental pacing-induced heart failure, administration of Ucn2 leads to improved cardiac output, a reduction of peripheral resistance and left atrial pressure, as well as to decreases in vasopressin, aldosterone, endothelin-1 and BNP (brain natriuretic peptide) plasma concentrations [13] . Our group has recently shown in the Dahl rat model of salt-induced hypertension that Ucn2 has immediate and longterm beneficial effects on systemic blood pressure [14] . In addition to the aforementioned effects, which may in part be related to reductions in peripheral resistance, Brar et al. [4] demonstrated that exogenous Ucn2 reduces infarct size after ischaemia/reperfusion injury in ex vivo Langendorff perfused rat hearts. This effect could be due to activation of the anti-apoptotic ERK1/2/p42/44 mitogen-activated protein kinase pathway [15] . The present study also indicates that low oxygen levels increase Ucn2 in rat neonatal cardiomyocytes.
In contrast with this increasing body of evidence supporting a potential beneficial use of exogenous Ucn2 in cardiovascular disease, almost no data are available on endogenous Ucn2
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regulation. Moreover, it is currently unknown how gene expression of hUcn2 (human Ucn2) is regulated. Therefore, the aim of the present study was to investigate whether the hUcn2 gene is regulated by hypoxic stress and to elucidate the molecular mechanism of its regulation. Our study demonstrates that hypoxia increases endogenous expression of Ucn2 mRNA in human cell lines and in rat neonatal cardiomyocytes and provides the first evidence that the transcription factor HIF1α (hypoxia-inducible factor 1α) transactivates the hUcn2 gene via specific enhancer sequences located downstream of the hUcn2 coding sequence.
MATERIALS AND METHODS

Cell culture and hypoxic treatment
The human rhabdomyosarcoma cell line TE-671 was obtained from the DSMZ (Deutsche Sammlung für Mikroorganismen und Zellkulturen, Germany). The embryonic rat heart-derived cell line H9c2 was provided by Dr L. Liaudet (Faculty of Biology and Medicine, University of Lausanne, Switzerland). NRVMs (neonatal rat ventricular cardiomyocytes) were isolated from neonatal Wistar rats as previously described in [16] . Neonatal rats were directly sacrificed without anaesthesia. 
Plasmids
Based on the preprourocortin 2 sequence (GenBank accession number NM_033199), fragments of the hUcn2 genomic region were amplified by PCR (for primers, see Supplementary Table  S1 at http://www.BiochemJ.org/bj/424/bj4240119add.htm). The PCR products were cloned into the pGEM-T vector, and then subcloned into the luciferase vectors pGL3basic and pGL3control (Promega). Point mutations within the putative HRE (hypoxiaresponse elements) were introduced using the QuikChange site-directed mutagenesis kit (Stratagene). Luciferase reporter constructs were confirmed by DNA sequencing. Primers and oligonucleotides were synthesized by Microsynth (Balgach, Switzerland).
Transfection and reporter assays
Cells were transiently transfected with the indicated luciferase constructs (450 ng) and pRL-CMV plasmid (50 ng) encoding for Renilla luciferase using FuGENE TM HD reagent (Roche Diagnostics). At 12 h after transfection, cells were incubated under normoxic or hypoxic conditions, or treated with CPX for 12 h. Firefly and Renilla luciferase activity was determined using a dual luciferase system (Promega) in a MicroLumatPlus luminometer (Berthold Technologies, Regensdorf, Switzerland). In all experiments, firefly luciferase activity was normalized to Renilla luciferase activity. The fold induction represents the ratio between CPX-or hypoxia-induced and normoxic firefly luciferase activity.
Suppression of HIF1α and HIF2α by siRNA
SMARTpool siRNA (small interfering RNA) targeting human HIF1α and HIF2α, and non-targeting siControl were designed and purchased from Dharmacon. TE-671 cells were transfected in serum-free DMEM using Lipofectamine TM -2000 (Invitrogen), followed by addition of a pool of four specific siRNAs against HIF1α, HIF2α or siControl (50 nmol/l). Cells were harvested 24 h after siRNA transfection.
RNA analysis
Total RNA was extracted using TriReagent (Sigma) and treated with DNase I (Ambion). RNA (2 μg) was reverse transcribed by random priming using a High Capacity cDNA reverse transcription kit (Applied Biosystems). The cDNA (5 μl) was analysed by real-time PCR on an ABI PRISM 7500 (Applied Biosystems, Rotkreuz, Switzerland), using iTAQ SYBR Green Supermix Kit (Bio-Rad, Reinach, Switzerland) or TaqMan Universal PCR Master Mix (Applied Biosystems). The sequence of primers, all designed to be intron spanning, are listed in Supplementary Table S1 . 18S rRNA was used as internal standard. Relative levels of target mRNA were calculated using the C T method.
HIF1α binding and competition assay
Nuclear extracts were prepared using the Nuclear Extract Kit (Active Motif). Protein content was determined with a Micro BCA (bicinchoninic acid) Protein Assay Kit (Pierce). HIF1α binding and competition assays were performed with the TransAM-HIF1 Kit (Active Motif), which uses a 96-well plate coated with an oligonucleotide containing the HRE from the EPO (erythropoietin) gene, and quantifies binding of HIF1α from nuclear extracts to this HRE. For competition experiments, synthetic oligonucleotides (20 pmol or 100 pmol, see Supplementary Table S1 ) were added to the plate before addition of the nuclear extract (5 μg). HIF1α binding was detected with an anti-HIF1α antibody followed by a horseradish peroxidase-conjugated secondary antibody. Absorbance was measured at 450 nm.
Immunoblotting
Protein expression of HIF1α was analysed in TE-671 cells exposed to normoxia, hypoxia or CPX. Nuclear extracts (5 μg) were separated on a 10 % SDS polyacrylamide gel and transferred on to PVDF membrane (Millipore). Membranes were blocked for 1 h in 5 % BSA in PBS-T (0.1 % Tween-20 in PBS). After blocking, the membranes were probed with an antibody against human HIF1α (Cell Signaling Technology) overnight at 4
• C. After three washes with PBS-T, membranes were incubated with the fluorochrome-conjugated secondary goat anti-rabbit antibody (LI-COR IRDye 800CW) in PBS-T for 1 h. Blots were washed three times with PBS-T, followed by scanning on a LI-COR Odyssey Infrared imaging system (LI-COR Biosciences).
Immunofluorescent staining
NRVMs were fixed on laminin-coated coverslips with 0.5 % paraformaldehyde, permeabilized with 0.1 % Triton X-100, and incubated with a rabbit anti-mouse Ucn2 antibody (provided by Dr W. Vale, Salk Institute for Biological Studies, San Diego, CA, U.S.A.) and an Alexa Fluor ® 488 dye-conjugated anti-rabbit secondary antibody (Molecular Probes, Invitrogen). Cells were examined using a Nikon fluorescence microscope. 
Statistical analysis
Unless otherwise stated, experiments were performed in triplicate in three independent experiments. Experimental data were analysed with Prism TM Graph Pad software. Results are expressed as means + − S.D. Results from reporter assays were analysed by one-way ANOVA. Comparisons between hypoxia or CPX and matched controls were made using one-way ANOVA analysis with Dunnett's or Bonferroni's multiple comparison test. P values <0.05 were considered to be statistically significant.
RESULTS
Human Ucn2 mRNA expression is induced by hypoxia and CPX
In the first series of experiments, we measured human Ucn2 mRNA and HIF1α protein levels under normoxic and hypoxic conditions in the TE-671 cell line, which is known to endogenously express Ucn2 [17] . Since no antibody against hUcn2 is available, we focused our analysis on hUcn2 transcript levels. Time course experiments revealed an increase in hUcn2 mRNA expression, which became significant at 4 h and reached a maximum after 8 h of exposure to hypoxia (8-fold, P < 0.001, Figure 1A ). At the later timepoints, hUcn2 mRNA declined, nevertheless at 24 h of hypoxia they were still 4-fold higher than in normoxic controls. HIF1 α protein levels in the nuclear extract of TE-671 cells were already increased after 2 h of hypoxia. Between 4 and 12 h, the transcription factor was stable at maximum levels, whereas after 24 h exposure to hypoxia it decreased again.
The possible involvement of HIF in the regulation of hUcn2 was confirmed by using CPX, which prevents the proteolytic degradation of HIF [18] . In contrast with the hypoxic treatment ( Figure 1A ), CPX increased HIF1α protein levels and induced hUcn2 gene expression for the full 24 h of CPX treatment ( Figure 1B) . Similar results were obtained at 12 h for the HIF1α target gene EGLN3 (egl nine homologue 3)/PHD3, which served as positive control (results not shown).
Induction of hUcn2 by hypoxia and CPX is mediated by HIF1α
To study the mechanism underlying the hUcn2 regulation, we examined whether reducing the expression of endogenous HIF1α or HIF2α decreases endogenous expression of hUcn2. TE-671 cells were transfected with specific siRNAs against HIF1α (siHIF1α) or HIF2α (siHIF2α). To control for non-specific effects, an equal amount of non-targeting siRNA (siControl) was transfected. siRNA targeting HIF1α decreased HIF1α mRNA levels to approx. 30 % of those in cells transfected with siControl (results not shown). Specific HIF1α-binding assays revealed that protein levels were reduced to 23.5 % in nuclear extracts of TE-671 cells transfected with siHIF1 ( Figure 1C ). Gene silencing of HIF1α abolished the effect of hypoxia and CPX on hUcn2 mRNA expression, confirming the involvement of HIF1α in endogenous hUcn2 regulation ( Figure 1D ). However, specific downregulation of HIF2α mRNA observed with the use of siRNA against HIF2α did not affect mRNA expression of hUcn2. 
The hUcn2 promoter is not involved in hypoxia-induced hUcn2 gene expression
To identify the regulatory sequence responsible for the induction of hUcn2 gene expression in response to hypoxia, the putative promoter of the hUcn2 gene containing two putative HREs matching the [A/GCGTG] consensus sequence of HIF1 was cloned into the pGL3basic vector upstream of a luciferase reporter gene. TE-671 cells were transfected with hUcn2 promoter constructs either containing (hUcn2 − 746 bp to + 593 bp) or lacking (hUcn2 − 493 bp to + 593 bp) these two putative HREs. Although both constructs activated the firefly luciferase reporter gene above control levels, hypoxia did not induce luciferase activity of any of the constructs, irrespective of the presence or absence of the two putative HREs (see Supplementary Figure S1 at http://www.BiochemJ.org/bj/424/bj4240119add.htm). These results suggest that the regulatory sequence responsible for the induction of hUcn2 gene expression under hypoxia or CPX is not located in the 5 -flanking region of hUcn2.
hUcn2 transcription is induced via an HRE in the 3 FLR (3 -flanking region)
It was previously shown that enhancer elements in the 3 -FLR of genes can activate transcription in response to hypoxia [19, 20] . Therefore we analysed the 3 FLR of the hUcn2 gene. This region of approx. 5 kb adjoins the coding region of the PFKFB4 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4) gene, which has its initiation site at position + 6975 bp downstream of the initiation site of the hUcn2 gene (see Supplementary Figure  S2 at http://www.BiochemJ.org/bj/424/bj4240119add.htm). In silico analysis using the TRANSFAC and rVISTA databases revealed four putative HREs in the region between the hUcn2 and PFKFB4 genes. One of these, located on the anti-sense strand and named HRE1 hereafter, showed a high matrix similarity and a complete core region of the HIF1α-binding site. The clear interspecies conservation of this HRE1 further supports its role as a functional element (UCSC Genome Bioinformatics). A second putative response element, which we called HRE2, was previously described to enhance HIF1α-mediated PFKFB4 gene expression in HeLa cells [21] .
To test their role as enhancers, we cloned several fragments of the 3 FLR of the hUcn2 gene downstream of the firefly luciferase gene in (a) the pGL3 − 746 bp vector containing the functional hUcn2 promoter, and (b) the pGL3control vector containing an internal SV40 promoter (Figure 2A ). TE-671 cells were transfected with the different constructs and exposed to normoxia or hypoxia for 12 h. Hypoxia significantly increased luciferase expression, specifically in the constructs containing the fragment 3 FLR3 (Figure 2A) .
To identify the putative HRE that drives hypoxic gene expression, a series of deletion constructs of the 3 FLR3 region was generated and tested for their response to hypoxia ( Figure 2B ). The reporter plasmid containing the deletion fragment 3 FLR3-2 with two HREs retained a strong response to hypoxia, similar to that of the full-length 3 FLR3 reporter construct ( Figure 2B ), indicating that both or at least one of the HREs are responsible for the upregulation of the luciferase gene. To determine whether the putative HRE1, the HRE2 or both HREs are important for the HIF1-dependent regulation, point mutations in the conserved residues of each or both HREs were generated by site-directed mutagenesis ( Figure 3A) . Compared with the wildtype construct, the hypoxia-or CPX-induced reporter activity was abolished in cells transfected with the construct harbouring the mutated HRE1 (mut1) motif. The construct with mutation in the HRE2 (mut2) motif still showed activation of the luciferase gene but to a lower extent than wild-type 3 FLR3 ( Figure 3B ). Reporter constructs with mutagenesis of both HREs were completely refractory to activation by hypoxia or CPX, indicating that both HREs are important for strong activation of luciferase gene expression. Our results support that the HRE1 motif is directly involved in the hypoxia-and CPX-inducible transcription of the hUcn2 gene.
siHIF1α abolishes the effect of hypoxia and CPX on hUcn2 3 FLR3
The importance of HIF1α in the regulation of the hUcn2 3 FLR3 construct was confirmed by co-transfection of TE-671 cells with 3 FLR3 constructs and siHIF1α. The reduced HIF1α levels fully abrogated the 3 FLR3-induced luciferase expression after exposure to hypoxia or CPX (Figure 4) , further supporting the TE-671 cells were transfected with siHIF1α or siControl together with the constructs pGL3 -746bp/3 FLR3 (A) or pGL3control/3 FLR3 (B), and exposed to hypoxia or CPX. siHIF1α reduced the luciferase activity induced by hypoxia or CPX. *P < 0.05 and **P < 0.01 compared with corresponding control vector. #P < 0.05 and ##P < 0.01 compared with corresponding wild-type 3 FLR3 vector.
notion that HIF1α activates hUcn2 gene expression via the HREs located in the 3 FLR3.
Hypoxia-and CPX-induced hUcn2 expression is independent of the HRE1 location
To test whether the HRE1 or HRE2, normally located downstream of the hUcn2 gene, can indeed act as an enhancer when placed in an upstream position, we cloned the 3 FLR3 containing HRE1 and HRE2 as wild-type and mutant versions separately or simultaneously upstream of the pGL3control vector. Similar to the results obtained with constructs that contained the 3 FLR3 variants downstream of the luciferase gene, the hypoxia-and CPX-induced luciferase activation was strongest in the 3 FLR3 containing both wild-type HRE1 and HRE2 ( Figure 5 ). Site-directed mutagenesis of HRE1 diminished the induction of luciferase by 74 and 75 % for hypoxia and CPX respectively. Mutation of HRE2 also reduced the induction, but to a lesser extent (64 and 56 % for hypoxia and CPX respectively). Mutation of both binding sites reduced luciferase expression to control levels ( Figure 5) . Thus HRE1 appears to be most important for the activation of luciferase gene expression in TE-671 cells, whereas HRE2 also seems to be partially involved in this process. In conclusion, HRE1 can act as an enhancer by its capacity to regulate transcription upstream or downstream of its target gene.
HIF1α binds to the hUcn2 HRE1 and HRE2
To prove that HIF1α binds to HRE1 and HRE2 in the 3 FLR of the hUcn2 gene, we performed HIF1α binding and competition ELISA assays. After 12 h of hypoxia, binding of HIF1α to the EPO HRE was stronger than under normoxic conditions (Figure 6 ), confirming presence of HIF1α in nuclear extracts of TE-671 cells. To determine if both HREs of the hUcn2 gene are able to bind HIF1α, we incubated nuclear extracts isolated from hypoxia-treated TE-671 cells with the HRE of the EPO oligonucleotide coated on a multiwell plate, and added hUcn2 HRE1 or HRE2 as competitors during the binding reaction. Figure 6 shows that addition of wild-type HRE1 to the assay reduced binding of HIF1α to the EPO HRE, whereas addition of mut HRE1 oligonucleotide was not effective even at a 5-fold higher concentration. Similar results were obtained for HRE2, although the binding of HIF1α to the wildtype HRE2 oligonucleotide was less effective compared with HRE1 ( Figure 6 ). Pretreatment of the nuclear extracts with an oligonucleotide containing the wild-type EGLN3 HRE, which we included as positive control, showed a clear competition, whereas the mutated EGLN3 oligonucleotide did not bind HIF1α.
Hypoxia increases Ucn2 expression in NRVMs
To investigate whether hypoxia regulates Ucn2 expression in a cardiac model system, we analysed rUcn2 (rat Ucn2) Figure 6 HIF1α binds to the HRE1 and HRE2 of the 3 FLR3 of the hUcn2 gene HIF1α-binding and competition assays were performed as described in the Materials and methods section. Nuclear extracts of hypoxic cells were preincubated with wild-type (wt) or mutated hUcn2 HRE1 or HRE2. The wild-type HREs abolished the binding of HIF1α to EPO HRE, whereas this competition was lost using the mutated HREs (mut). Oligonucleotides of the hEGLN3 gene were used as positive control. Values represent the means of duplicate determinations in this representative experiment. The experiment was repeated three times yielding the same result.
expression by real time RT-PCR (reverse transcription-PCR) and immunofluorescent staining in NRVMs. Similar to the results in the human cell line, exposure of cardiomyocytes to hypoxia for 12 h resulted in a 7-fold increase of rUcn2 mRNA levels (P < 0.01, Figure 7A ). Similarly, staining of NRVMs with an antibody against mouse Ucn2 demonstrated increased immunoreactivity in myocytes exposed to hypoxia compared with cells under normoxic conditions ( Figure 7B ). To test whether HRE1, which we identified as the most important element for HIF1α-dependent regulation of hUcn2 expression, is also involved in cardiac Ucn2 regulation, experiments described in Figure 3 were repeated in the cardiac-derived cell line H9c2. Transfection with constructs containing the wild-type HREs in the hUcn2 − 746bp/3 FLR3 or pGL3control/3 FLR3 induced a significant upregulation of luciferase expression, whereas luciferase expression of constructs with mutation of one or both HREs diminished or completely abolished the hypoxia-driven induction ( Figure 7C ).
DISCUSSION
In the present study, we report for the first time that transcription of the human Ucn2 gene is activated in response to hypoxic stress by a mechanism involving the transcription factor HIF1α. We have demonstrated that both hypoxia and CPX increase endogenous levels of Ucn2 mRNA in the human rhabdomyosarcoma cell line TE-671. Using siRNA technology, specific downregulation of HIF1α but not HIF2α abrogated the hUcn2 induction by hypoxia or CPX, proving the involvement of HIF1α. Significant increases in Ucn2 mRNA levels occurred also in rat neonatal cardiomyocytes after exposure to hypoxia, and were confirmed at the protein level.
HIF1α and HIF2α are known as key regulators of gene expression in hypoxia. The induction of hUcn2 gene expression by HIF1α is in line with findings that this isoform is the most ubiquitously expressed member of the HIF family, whereas HIF2α is only expressed in certain cell types [22] . Low oxygen tension and treatment with iron chelators such as CPX prevent the degradation of the HIF transcription factors by the ubiquitin/proteasome system, resulting in an induction of more than 40 target genes, including those for cell survival and glycolysis [23, 24] . The main regulators of HIF degradation, the prolyl hydroxylases EGLN1 and 3, are themselves inducible by HIF. This HIF-dependent auto-regulatory mechanism is important for cellular adaptation to low oxygen and explains the downregulation of HIF-responsive genes after long periods of hypoxia [25] . We demonstrated the relationship between hypoxia, HIF1α and hUcn2 expression in time-course experiments, in which the expression of hUcn2 mRNA followed that of HIF1α protein under conditions of hypoxia and CPX. In the case of hypoxia, an increase in HIF1α protein and a decrease at later time-points supported that an auto-regulatory feedback loop was activated, as reported previously [25] . Consistently, stabilization of HIF1α by CPX did not show such decrease of HIF1α and was correlated with a stable increase of hUcn2 transcript levels over 24 h.
In general, the regulation of target genes by HIF1α depends on the interaction of the transcription factor with its specific DNA consensus sequence 5 -RCGTG-3 [26] , which is mostly part of the promoter region of the regulated gene. However, fragments of the hUcn2 promoter containing two putative HRE-like sequences did not induce stronger transcription under hypoxic conditions than the promoter lacking these elements. In three sets of experiments, we determined that two responsive elements located downstream of the hUcn2 coding sequence, HRE1 and HRE2, are important for HIF1α-mediated gene transcription (Supplementary Figure S2) . These three experiments were: (1) a fragment of the 3 -FLR containing HRE1 and HRE2 activated luciferase under hypoxic conditions when cloned downstream of an SV40 or hUcn2 promoter-luciferase construct; (2) cotransfection with siRNA against HIF1α abolished hypoxia-induced luciferase expression of these constructs; (3) site-directed mutagenesis of HRE1, located on the minus strand at position + 6482 to + 6487 bp from the hUcn2 transcription initiation site, reduced transcription of reporter constructs by 75 %, whereas mutagenesis of both HRE1 and HRE2 completely abolished luciferase activation, suggesting that these HREs work synergistically.
Similar to our observation for Ucn regulation, a regulatory sequence in the 3 -flanking region of the human EPO gene activated gene transcription in response to hypoxia. This regulation was position-and orientation-independent, which classifies the involved sequence as an enhancer sequence [19] . The model for EPO gene transactivation assumes a physical interaction of the enhancer with promoter elements and the transcriptional machinery by forming a loop of the DNA intervening sequence [27] . In our study, we provide evidence that HRE1, normally located downstream of the hUcn2 gene initiation site, also induces transcription when positioned upstream of a reporter gene, confirming our hypothesis that this sequence is an enhancer sequence. In our transfection experiments, the inducibility of luciferase was not as robust as that of endogenous hUcn2 mRNA. This might be explained by the fact that we cloned only a short part (3 FLR3) of the full-length 3 FLR into the luciferase vector, which may have resulted in suboptimal physical interaction with the promoter. In addition, cell stress of the transfection procedure and treatment may have contributed to the lower inducibility.
Binding of HIF1α to the HRE of the EPO gene was completely shifted by the presence of an oligonucleotide containing the wild-type HRE1. Mutation of HRE1 resulted in a loss of this competition, proving specificity of the DNA-protein interaction. Taken together, our results provide evidence that the identified HRE1 is required for HIF1α-dependent hUcn2 gene transcription. We cannot, however, rule out that additional mechanisms are involved in the induction of hUcn2 expression by hypoxia. For example, the maximal function of the hypoxia enhancer of EPO requires an EP17 (CACCC box) sequence [28] , which we also identified in the hUcn2 promoter by in silico analysis. Furthermore, transcriptional regulation of other genes such as angiopoietin-2, VEGF (vascular endothelial growth factor) and endothelin-1 has been shown to require co-operation and interaction between HIF and other transcription factors such as GATA-2 (GATA-binding protein 2), AP-1 (activator protein 1) or Ets (V-ets erythroblastosis virus E26 oncogene homologue 1) [29, 30] .
HIF1α transcriptional targets are involved in cell survival, hormonal regulation, energy metabolism, angiogenesis and the regulation of the vasomotor [31] . Generally, tissue HIF levels are low, but are strikingly increased by systemic hypoxia or tissue ischaemia. HIF-mediated beneficial metabolic adaptations to low oxygen tension have been shown to promote cell survival in the context of acute myocardial ischaemia [24, 32] . Ischaemic preconditioning experiments in rabbits demonstrate that there is a phase of protection lasting approx. 12-24 h [33] . On the other hand, chronic ischaemia or chronic activation of the HIF pathway lead to maladaptive responses and may contribute to cardiac degeneration and progression to heart failure [34] . In the present study, we showed that hypoxic stress increases Ucn2 transcripts in rat neonatal cardiomyocytes, confirming an earlier report [15] . Using immunofluorescent labelling, we demonstrated corresponding increases in Ucn2 protein. Furthermore, we confirmed that the HRE1 identified as the most important sequence for hypoxia-mediated regulation of the human gene was also capable of inducing Ucn2 gene expression in heart-derived H9c2 cells.
Previous studies have shown that Ucn2 protects neonatal rat cardiomyocytes from apoptotic cell death induced by ischaemia/reperfusion injury and reduces infarct size in a Langendorff-perfused rat heart model [4, 15] . The results of our study extend these previous studies to the human Ucn2 gene, demonstrating hypoxia-induced regulation via a direct and rapid mechanism involving HIF1α, HRE1 and to a smaller extent also HRE2. In view of the cardioprotective actions of Ucn2, our findings imply that HIF1α-driven upregulation of Ucn2 expression is one of the factors that may help to preserve contractile function and prevent apoptosis during the acute phase of cardiac ischaemia.
In conclusion, we have identified an HRE in the 3 -flanking region of the hUcn2 gene that binds HIF1α and regulates transcription in response to hypoxia, revealing for the first time a molecular mechanism of hUcn2 gene regulation. The induction of hUcn2 expression by low oxygen tension may confer a survival advantage on cardiac myocytes in ischaemic conditions. The findings of the present study expand the current knowledge of the molecular regulatory mechanisms in ischaemic heart disease by functionally integrating Ucn2 in the hypoxic signalling pathway.
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